AstraZeneca
The Pricing & Value Manager at AstraZeneca drives strategic pricing and value decisions to enhance patient access to innovative medicines. This role involves collaborating with cross-functional teams to translate market and financial insights into actionable recommendations that balance patient access, sustainability, and business growth. The position requires strong analytical capabilities and the ability to influence stakeholders across Market Access, HEOR, Commercial, and Finance departments.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
Head of Value, Access and Pricing, Canada
Revolution Medicines
Cluster V&A Director
Kyowa Kirin International plc
Senior Director, Global Value, Access & Pricing NSCLC Oncology
Revolution Medicines
Senior Director of Global Pricing, Value & Access
C0001163629T1
Senior Director Global Pricing, Value & Access (GPS) - UK (remote)
USAJOBS
Value & Access Manager
Novartis